Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating pain control methods after total knee replacement surgery for people with osteoarthritis of the knee. The study compares a new long-acting medication called Zynrelef with two common pain treatments a nerve block called the adductor canal block and a standard injection into the knee during surgery. The goal is to find pain control options that may reduce or eliminate the need for opioid pain medicines, which can have side effects and risks. Participants will be randomly assigned to one of three groups the standard periarticular injection group receiving a mix of ropivacaine, epinephrine, and ketorolac during surgery the adductor canal block group receiving a nerve block before surgery or the Zynrelef group receiving extended-release bupivacaine injected into the knee before closure along with a smaller dose of the standard injection. All participants will receive the same medicines before and after surgery and follow the same physical therapy and follow-up schedules. During the study, participants will record their pain levels and pain medicine use for several weeks after surgery. Researchers will measure postoperative pain scores using a numeric rating scale for the first five days after surgery and monitor outcomes such as emergency visits, readmissions, complications, and mortality for 90 days. Participants will have follow-up visits and assessments as part of routine care, and the study will monitor safety and recovery progress over the months following surgery.
Actively Recruiting
Healthy Volunteer
Researchers are exploring how multi-cancer detection MCD tests might work as tools to screen for multiple cancers at once in adults aged 45 to 75 without cancer. The study aims to understand the performance of two different MCD tests compared to a control group and how patients and doctors handle both normal and abnormal test results. This feasibility study will inform future trials and help improve early cancer detection when treatment is most effective. Participants will be randomly assigned to one of three groups one group will undergo the Shield MCD test, another the Avantect MCD test, and the third will serve as a control group with blood collection only. Blood samples are collected at enrollment and again after one year. Participants at unblinded sites receive their test results, and those with abnormal findings follow up with their clinicians for further testing. After the active study period, participants are followed passively for up to 10 years. During the study, participants complete questionnaires and provide blood samples on schedule. Researchers collect medical record data and monitor participant adherence, diagnostic outcomes, anxiety related to testing, and the accuracy of the tests in predicting cancer origins. Primary outcomes include enrollment feasibility, questionnaire completion, blood sample provision, and follow-up retention. Secondary outcomes evaluate diagnostic resolution, complications, and psychological impact. This comprehensive approach helps assess the practical aspects of MCD testing and its potential role in cancer screening.